Rebalix
iShares · sheet of 10 September 2026
iShares · sheet of 10 September 2026ETF sheet · official issuer and register data
iShares S&P 500 Health Care Sector UCITS ETF EUR Hedged
IUHE · IE00BMBKBZ46 · class Hedged · EUR · domicile Ireland
Equity · United States · Health care · Large capEUR-hedged share classSFDR art. 6
Index tracked: S&P 500 Capped 35/20 Health Care Index NTR (USD)
- TER
- 0.18%+ trans. 0.00%
- Fund size
- 124 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingquarterly
Launch 15 Jun 2020 · costs from the KID as of 2 Sept 2026 · 60 securities held · 5 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the S&P 500 Capped 35/20 Health Care Index, the Fund’s benchmark index (“Index”). The Share Class, via the Fund is passively managed and invests in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index. The Index measures the performance of stocks from S&P 500 Index which are within the Global Industry Classification…
Performance since series start (in euro) — base 100
15 Jun 2020 → 31 Aug 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +23.4% |
| 3 years | +25.3% |
| 5 years | +20.3% |
| 10 years | series too young |
| Since series start | +66.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 16.29% | 14.72% | 15.20% |
| Max drawdown | −11.35% | −19.68% | −19.68% |
| Sharpe | 1.01 | 0.24 | 0.03 |
| Sortino | 1.67 | 0.34 | 0.04 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IUHE · IE00BMBKBZ461
RebalixIUHE · IE00BMBKBZ46 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: hedged class: the issuer’s published index is unhedged — the gap would measure the exchange rate, not replication. We don’t show it · the TD of the unhedged class is on the sheet of IUHC
Distributions · per share, in EUR
Frequency: quarterly · last 12 months: 0.08 EUR (1.06% of NAV) · last ex-date 18 Jun 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.04 | — |
| 2025 | 4 | 0.08 | +1.24% |
| 2024 | 4 | 0.08 | +1.23% |
| 2023 | 4 | 0.08 | +1.20% |
| 2022 | 4 | 0.08 | +1.12% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 60 securities · top-10 weight = 60.4%
| Top holdings | Weight |
|---|---|
| 14.9% | |
| 10.4% | |
| 7.4% | |
| 5.9% | |
| 5.7% | |
| 3.8% | |
| 3.7% | |
| 3.1% | |
| 3.0% | |
| 2.6% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
IUHE · Börse Hamburg, Börse Hannover, Börse München / gettex, Euronext Amsterdam, Tradegate Exchange
+ 17 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BMBKBZ46
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BMBKBZ46
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IUHE · IE00BMBKBZ462